1
|
Cui Y, Michael H, Tanser F, Tchetgen Tchetgen E. Instrumental variable estimation of the marginal structural Cox model for time-varying treatments. Biometrika 2023; 110:101-118. [PMID: 36798841 PMCID: PMC9919489 DOI: 10.1093/biomet/asab062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Indexed: 11/14/2022] Open
Abstract
Robins (1998) introduced marginal structural models, a general class of counterfactual models for the joint effects of time-varying treatments in complex longitudinal studies subject to time-varying confounding. Robins (1998) established the identification of marginal structural model parameters under a sequential randomization assumption, which rules out unmeasured confounding of treatment assignment over time. The marginal structural Cox model is one of the most popular marginal structural models for evaluating the causal effect of time-varying treatments on a censored failure time outcome. In this paper, we establish sufficient conditions for identification of marginal structural Cox model parameters with the aid of a time-varying instrumental variable, in the case where sequential randomization fails to hold due to unmeasured confounding. Our instrumental variable identification condition rules out any interaction between an unmeasured confounder and the instrumental variable in its additive effects on the treatment process, the longitudinal generalization of the identifying condition of Wang & Tchetgen Tchetgen (2018). We describe a large class of weighted estimating equations that give rise to consistent and asymptotically normal estimators of the marginal structural Cox model, thereby extending the standard inverse probability of treatment weighted estimation of marginal structural models to the instrumental variable setting. Our approach is illustrated via extensive simulation studies and an application to estimating the effect of community antiretroviral therapy coverage on HIV incidence.
Collapse
Affiliation(s)
- Y Cui
- Department of Statistics and Data Science, National University of Singapore, 6 Science Drive 2, 117546 Singapore
| | - H Michael
- Department of Mathematics and Statistics, University of Massachusetts, 710 N. Pleasant Street, Amherst, Massachusetts 01003, U.S.A
| | - F Tanser
- Lincoln Institute for Health, University of Lincoln, Brayford Way, Brayford Pool, Lincoln LN6 7TS, U.K
| | - E Tchetgen Tchetgen
- Department of Statistics and Data Science, The Wharton School, University of Pennsylvania, 265 South 37th Street, Philadelphia, Pennsylvania 19104, U.S.A
| |
Collapse
|
3
|
Patel SY, Huskamp HA, Barnett ML, Zubizarreta JR, Zachrison KS, Busch AB, Wilcock AD, Mehrotra A. Association Between Telepsychiatry Capability and Treatment of Patients With Mental Illness in the Emergency Department. Psychiatr Serv 2022; 73:403-410. [PMID: 34407629 PMCID: PMC8857309 DOI: 10.1176/appi.ps.202100145] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Because of limited access to psychiatrists, patients with acute mental illness in some emergency departments (EDs) may wait days for a consultation in the ED or as a medical-surgical admission. The study assessed whether telepsychiatry improves access to care and decreases ED wait times and hospital admissions. METHODS ED visits with a primary diagnosis of mental illness were identified from 2010-2018 Medicare claims. A total of 134 EDs across 22 states that implemented telepsychiatry between 2013 and 2016 were matched 1:1 with control EDs without telepsychiatry on several characteristics, including availability of in-person psychiatrist consultations. Outcomes included patients' likelihood of admission to a medical-surgical or psychiatric bed, mental illness spending, prolonged ED length of stay (LOS) (two or more midnights in the ED), 90-day mortality, and outpatient follow-up care. Using a difference-in-difference design, changes in outcomes between the 3 years before telepsychiatry adoption and the 2 years after were examined. RESULTS There were 172,708 ED mental illness visits across the 134 matched ED pairs in the study period. Telepsychiatry adoption was associated with increased admissions to a psychiatric bed (differential increase, 4.3 percentage points; p<0.001), decreased admissions to a medical-surgical bed (differential decrease, 2.0 percentage points; p<0.001), increased likelihood of a prolonged ED LOS (differential increase, 3.0 percentage points; p<0.001), and increased mental illness spending (differential increase, $292; p<0.01). CONCLUSIONS Telepsychiatry adoption was associated with a lower likelihood of admission to a medical-surgical bed but an increased likelihood of admission to a psychiatric bed and a prolonged ED LOS.
Collapse
Affiliation(s)
- Sadiq Y Patel
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Haiden A Huskamp
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Michael L Barnett
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - José R Zubizarreta
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Kori S Zachrison
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Alisa B Busch
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Andrew D Wilcock
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| | - Ateev Mehrotra
- Department of Health Care Policy, Harvard Medical School, Boston (Patel, Huskamp, Zubizarreta, Busch, Mehrotra); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston (Mehrotra); Department of Medicine, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston (Barnett); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Statistics, Harvard University, Cambridge (Zubizarreta); Department of Emergency Medicine, Massachusetts General Hospital, Boston (Zachrison); McLean Hospital, Belmont, Massachusetts (Busch); Department of Family Medicine, University of Vermont College of Medicine, Burlington (Wilcock)
| |
Collapse
|
8
|
Kessler RC, Bossarte RM, Luedtke A, Zaslavsky AM, Zubizarreta JR. Machine learning methods for developing precision treatment rules with observational data. Behav Res Ther 2019; 120:103412. [PMID: 31233922 DOI: 10.1016/j.brat.2019.103412] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Revised: 05/15/2019] [Accepted: 05/26/2019] [Indexed: 12/28/2022]
Abstract
Clinical trials have identified a variety of predictor variables for use in precision treatment protocols, ranging from clinical biomarkers and symptom profiles to self-report measures of various sorts. Although such variables are informative collectively, none has proven sufficiently powerful to guide optimal treatment selection individually. This has prompted growing interest in the development of composite precision treatment rules (PTRs) that are constructed by combining information across a range of predictors. But this work has been hampered by the generally small samples in randomized clinical trials and the use of suboptimal analysis methods to analyze the resulting data. In this paper, we propose to address the sample size problem by: working with large observational electronic medical record databases rather than controlled clinical trials to develop preliminary PTRs; validating these preliminary PTRs in subsequent pragmatic trials; and using ensemble machine learning methods rather than individual algorithms to carry out statistical analyses to develop the PTRs. The major challenges in this proposed approach are that treatment are not randomly assigned in observational databases and that these databases often lack measures of key prescriptive predictors and mental disorder treatment outcomes. We proposed a tiered case-cohort design approach that uses innovative methods for measuring and balancing baseline covariates and estimating PTRs to address these challenges.
Collapse
Affiliation(s)
- Ronald C Kessler
- Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
| | - Robert M Bossarte
- West Virginia University Injury Control Research Center, Morgantown, WV, USA; Department of Behavioral Medicine and Psychiatry, West Virginia University, Morgantown, WV, USA; VISN 2 Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, Canandaigua, NY, USA
| | - Alex Luedtke
- Department of Statistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Alan M Zaslavsky
- Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
| | - Jose R Zubizarreta
- Department of Health Care Policy, Harvard Medical School, Boston, MA, USA; Department of Statistics, Faculty of Arts and Sciences, Harvard University, Cambridge, MA, USA
| |
Collapse
|